Methionine-enkephalin secreted by human colorectal cancer cells suppresses T lymphocytes

Cancer Science

Volumn 100, Issue 3, 2009, Pages 497-502

  Ohmori, Hitoshi ^a   Fujii, Kiyomu ^a   Sasahira, Tomonori ^a   Luo, Yi ^a   Isobe, Mamoru ^a   Tatsumoto, Naokuni ^b   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Miyoshi Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METENKEPHALIN; STRESS ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CD4+ T LYMPHOCYTE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; RISK FACTOR; T LYMPHOCYTE; ANIMAL; CELL PROLIFERATION; COLORECTAL TUMOR; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; TUMOR ESCAPE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; COLORECTAL NEOPLASMS; ENKEPHALIN, METHIONINE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; RATS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 62849084625     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01073.x     Document Type: Article

References (34)

1. Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S, Ohmori H. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol 2005; 166: 751-760.
2. Kuniyasu H, Sasaki T, Sasahira T, Ohmori H, Takahashi T. Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer. Pathobiology 2004; 71: 129-36.
3. Dong H, Strome SE, Salomao DR et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat Med 2002; 8: 793-800.
4. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5: 938-42.
5. + T cells. Clin Cancer Res 2006; 12: 411-16.
6. Sacerdote P. Opioids and the immune system. Palliat Med 2006; 20: S9-15.
7. Sharp BM, Shahabi NA, Heagy W et al. Dual signal transduction through δ opioid receptors in a transfected human T-cell line. Proc Natl Acad Sci USA 1996; 93: 8294-9.
8. Martin-Kleiner I, Balog T, Gabrilovac J. Signal transduction induced by opioids in immune cells: A review. Neuroimmunomodulation 2006; 13: 1-7.
9. Sharp BM. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun 2006; 20: 9-14.
10. Singhal P, Kapasi A, Reddy K, Franki N. Opiates promote T cell apoptosis through JNK and caspase pathway. Adv Exp Med Biol 2001; 493: 127-35.
11. Davis WG, Tormey WP, Delaney PV. Enkephalins in large bowel malignancy and in acute appendicitis. Gut 1979; 20: 865-7.
12. Kuniyasu H, Yasui W, Shinohara H et al. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 2000; 157: 1523-35.
13. Kuniyasu H, Yoshida K, Yokozaki H et al. Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas. Jpn J Cancer Res 1991; 82: 969-73.
14. Sasaki T, Yoshida K, Shimura H et al. Inhibitory effect of linoleic acid on transformation of IEC6 intestinal cells by in vitro azoxymethane treatment. Int J Cancer 2006; 118: 593-9.
15. Kuniyasu H, Yasui W, Kitahara K et al. Growth inhibitory effect of interferon-β is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. Cell Growth Differ 1997; 8: 47-52.
16. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-68.
17. Larsson LI. Peptide immunocytochemistry. Prog Histochem Cytochem 1981; 13: 1-85.
18. Cadet P, Rasmussen M, Zhu W, Tonnesen E, Mantione KJ, Stefano GB. Endogenous morphinergic signaling and tumor growth. Front Biosci 2004; 9: 3176-86.
19. Roy S, Loh HH. Effects of opioids on the immune system. Neurochem Res 1996; 21: 1375-86.
20. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 1998; 83: 36-44.
21. + T cells and DOR-dependent suppression of HIV-1 expression. J Immunol 2001; 167: 1097-102.
22. Spetea M, Harris HE, Berzetei-Gurske IP, Klareskog L, Schmidhammer H. Binding, pharmacological and immunological profiles of the δ-selective opioid receptor antagonist HS 378. Life Sci 2001; 69: 1775-82.
23. Gabrilovac J, Marotti T. Gender-related differences in murine T- and B-lymphocyte proliferative ability in response to in.vivo Met 5 enkephalin administration. Eur J Pharmacol 2000; 392: 101-8.
24. Mayer P, Tischmeyer H, Jayasinghe M et al. A delta opioid receptor lacking the third cytoplasmic loop is generated by atypical mRNA processing in human malignomas. FEBS Lett 2000; 480: 156-60.
25. Fukuda K, Kato S, Morikawa H, Shoda T, Mori K. Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 1996; 67: 1309-16.
26. Shahabi NA, Daaka Y, McAllen K, Sharp BM. δ Opioid receptors expressed by stably transfected jurkat cells signal through the map kinase pathway in a ras-independent manner. J Neuroimmunol 1999; 94: 48-57.
27. Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 1998; 273: 1839-42.
28. Sharp BM. Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv Exp Med Biol 2003; 521: 98-105.
29. Wick MJ, Minnerath SR, Roy S, Ramakrishnan S, Loh HH. Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J Neuroimmunol 1996; 64: 29-36.
30. Shahabi NA, McAllen K, Matta SG, Sharp BM. Expression of δ opioid receptors by splenocytes from SEB-treated mice and effects on phosphorylation of MAP kinase. Cell Immunol 2000; 205: 84-93.
31. Sharp BM, McKean DJ, McAllen K, Shahabi NA. Signaling through δ opioid receptors on murine splenic T cells and stably transfected Jurkat cells. Ann N Y Acad Sci 1998; 840: 420-4.
32. Shahabi NA, McAllen K, Sharp BM. Phosphorylation of activating transcription factor in murine splenocytes through δ opioid receptors. Cell Immunol 2003; 221: 122-7.
33. Sun PLH. Transcriptional regulation of mouse δ-opioid receptor gene. Ikaros-2 and upstream stimulatory factor synergize in trans-activating mouse δ-opioid receptor gene in T cells. J Biol Chem 2003; 278: 2304-8.
34. Iishi H, Tatsuta M, Baba M, Okuda S, Taniguchi H. Enhancement by methionine enkephalin of colon carcinogenesis induced by azoxymethane. Cancer Res 1991; 51: 785-8.